Effects of Postconditioning, Preconditioning and Perfusion of L-carnitine During Whole Period of Ischemia/ Reperfusion on Cardiac Hemodynamic Functions and Myocardial Infarction Size in Isolated Rat Heart

Overview

Journal Iran J Basic Med Sci

Publisher Mashhad University of Medical Sciences

Specialty General Medicine

Date 2013 Nov 20

PMID 24250945

Citations 4

Authors

Moslem Najafi

Affiliations

Soon will be listed here.

Abstract

Objective(s): In the present work, the effects of L-carnitine (LC) on postischemic cardiac hemodynamic functions and infarction size were studied in isolated rat heart.

Materials And Methods: The hearts were subjected to 30 min regional ischemia followed by 120 min reperfusion. Then they were perfused by a drug-free or LC-enriched Krebs-Henseleit (K/H) solution during ischemia/ reperfusion (I/R) (Protocol 1), 10 min before ischemia induction (Protocol 2; preconditioning group) or the first 10 min of reperfusion (Protocol 3; postconditioning group).

Results: The perfusion of LC in protocol 1 significantly reduced left ventricular end diastolic pressure (LVEDP) (P<0.05), and increased left ventricular developed pressure (LVDP) (P<0.05), rate pressure product (RPP) (P<0.01) and coronary flow rate (CFR) (P<0.05). The short-term preischemic administration of LC in protocol 2 improved RPP, CFR and decreased the extent of LVEDP elevation. However, protective effects of LC in this protocol were low compared to the whole period perfusion. In protocol 3, LC preserved postischemic cardiac functions not as much as the other protocols. In addition, infarct size significantly decreased by LC in all protocols as opposed to the control group (P<0.001).

Conclusion: The results of the present work showed that LC produced protective effects against I/R injury. These protective actions were reversed by concomitant use of etomoxir (a CPT-I inhibitor), suggesting that the efficacy of LC could be due to its mitochondrial action, probably related to the raise in glucose oxidation of the reperfused hearts.

Citing Articles

Potential protective effects of L-carnitine against myocardial ischemia/reperfusion injury in a rat model.

Farag A, Elfadadny A, Mandour A, Ngeun S, Aboubakr M, Kaneda M Environ Sci Pollut Res Int. 2024; 31(12):18813-18825.

PMID: 38349499 DOI: 10.1007/s11356-024-32212-5.

A review on experimental surgical models and anesthetic protocols of heart failure in rats.

Farag A, Mandour A, Hendawy H, Elhaieg A, Elfadadny A, Tanaka R Front Vet Sci. 2023; 10:1103229.

PMID: 37051509 PMC: 10083377. DOI: 10.3389/fvets.2023.1103229.

Total flavonoid extract from Nutt. protects rats against myocardial ischemia/reperfusion injury.

Zhang Y, Yuan C, Fang H, Li J, Su S, Chen W Iran J Basic Med Sci. 2016; 19(9):1016-1023.

PMID: 27803790 PMC: 5080418.

Effects of mild hypothermia therapy on the levels of glutathione in rabbit blood and cerebrospinal fluid after cardiopulmonary resuscitation.

Zhao H, Chen Y Iran J Basic Med Sci. 2015; 18(2):194-8.

PMID: 25810895 PMC: 4366732.

References

Hausenloy D, Duchen M, Yellon D . Inhibiting mitochondrial permeability transition pore opening at reperfusion protects against ischaemia-reperfusion injury. Cardiovasc Res. 2003; 60(3):617-25. DOI: 10.1016/j.cardiores.2003.09.025. View

Oyanagi E, Yano H, Uchida M, Utsumi K, Sasaki J . Protective action of L-carnitine on cardiac mitochondrial function and structure against fatty acid stress. Biochem Biophys Res Commun. 2011; 412(1):61-7. DOI: 10.1016/j.bbrc.2011.07.039. View

Siktar E, Ekinci D, Siktar E, Beydemir S, Gulcin I, Gunay M . Protective role of L-carnitine supplementation against exhaustive exercise induced oxidative stress in rats. Eur J Pharmacol. 2011; 668(3):407-13. DOI: 10.1016/j.ejphar.2011.07.032. View

Najafi M, Javidnia A, Ghorbani-haghjo A, Mohammadi S, Garjani A . Pharmacological preconditioning with L-carnitine: relevance to myocardial hemodynamic function and glycogen and lactate content. Pak J Pharm Sci. 2010; 23(3):250-5. View

Calo L, Pagnin E, Davis P, Semplicini A, Nicolai R, Calvani M . Antioxidant effect of L-carnitine and its short chain esters: relevance for the protection from oxidative stress related cardiovascular damage. Int J Cardiol. 2005; 107(1):54-60. DOI: 10.1016/j.ijcard.2005.02.053. View

Tarantini G, Scrutinio D, Bruzzi P, Boni L, Rizzon P, Iliceto S . Metabolic treatment with L-carnitine in acute anterior ST segment elevation myocardial infarction. A randomized controlled trial. Cardiology. 2006; 106(4):215-23. DOI: 10.1159/000093131. View

Zacharowski K, Blackburn B, Thiemermann C . Ranolazine, a partial fatty acid oxidation inhibitor, reduces myocardial infarct size and cardiac troponin T release in the rat. Eur J Pharmacol. 2001; 418(1-2):105-10. DOI: 10.1016/s0014-2999(01)00920-7. View

Broderick T, CIFUENTES J, Green D, Paulson D . Short-term carnitine deficiency does not alter aerobic rat heart function but depresses reperfusion recovery after ischemia. Can J Physiol Pharmacol. 2001; 79(10):892-7. View

Colonna P, Iliceto S . Myocardial infarction and left ventricular remodeling: results of the CEDIM trial. Carnitine Ecocardiografia Digitalizzata Infarto Miocardico. Am Heart J. 2000; 139(2 Pt 3):S124-30. DOI: 10.1067/mhj.2000.103918. View

10.

Arsenian M, NEW P, Cafasso C . Safety, tolerability, and efficacy of a glucose-insulin-potassium-magnesium-carnitine solution in acute myocardial infarction. Am J Cardiol. 1996; 78(4):477-9. DOI: 10.1016/0002-9149(97)00001-5. View

11.

Cui J, Das D, Bertelli A, Tosaki A . Effects of L-carnitine and its derivatives on postischemic cardiac function, ventricular fibrillation and necrotic and apoptotic cardiomyocyte death in isolated rat hearts. Mol Cell Biochem. 2003; 254(1-2):227-34. DOI: 10.1023/a:1027368018064. View

12.

Lango R, Smolenski R, NARKIEWICZ M, Suchorzewska J, Lysiak-Szydlowska W . Influence of L-carnitine and its derivatives on myocardial metabolism and function in ischemic heart disease and during cardiopulmonary bypass. Cardiovasc Res. 2001; 51(1):21-9. DOI: 10.1016/s0008-6363(01)00313-3. View

13.

Broderick T, Panagakis G, DiDomenico D, Gamble J, Lopaschuk G, Shug A . L-carnitine improvement of cardiac function is associated with a stimulation in glucose but not fatty acid metabolism in carnitine-deficient hearts. Cardiovasc Res. 1995; 30(5):815-20. View

14.

Wu J, Corr P . Palmitoylcarnitine increases [Na+]i and initiates transient inward current in adult ventricular myocytes. Am J Physiol. 1995; 268(6 Pt 2):H2405-17. DOI: 10.1152/ajpheart.1995.268.6.H2405. View

15.

Neely J, Morgan H . Relationship between carbohydrate and lipid metabolism and the energy balance of heart muscle. Annu Rev Physiol. 2009; 36:413-59. DOI: 10.1146/annurev.ph.36.030174.002213. View

16.

Lopaschuk G . Regulation of carbohydrate metabolism in ischemia and reperfusion. Am Heart J. 2000; 139(2 Pt 3):S115-9. DOI: 10.1067/mhj.2000.103919. View

17.

Ferrari R, Merli E, Cicchitelli G, Mele D, Fucili A, Ceconi C . Therapeutic effects of L-carnitine and propionyl-L-carnitine on cardiovascular diseases: a review. Ann N Y Acad Sci. 2004; 1033:79-91. DOI: 10.1196/annals.1320.007. View

18.

Singh R, Niaz M, Agarwal P, Beegum R, Rastogi S, Sachan D . A randomised, double-blind, placebo-controlled trial of L-carnitine in suspected acute myocardial infarction. Postgrad Med J. 1996; 72(843):45-50. PMC: 2398308. DOI: 10.1136/pgmj.72.843.45. View

19.

Najafi M, Garjani A, Maleki N, Eteraf Oskouei T . Antiarrhythmic and arrhythmogenic effects of L-carnitine in ischemia and reperfusion. Bull Exp Biol Med. 2009; 146(2):210-3. DOI: 10.1007/s10517-008-0249-5. View

20.

Haigney M, Lakatta E, Stern M, Silverman H . Sodium channel blockade reduces hypoxic sodium loading and sodium-dependent calcium loading. Circulation. 1994; 90(1):391-9. DOI: 10.1161/01.cir.90.1.391. View